Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
ACS Infectious Diseases|November 22, 2017
Transformation of the Anticancer Drug Doxorubicin in the Human Gut MicrobiomeAustin Yan, Elizabeth Culp, Julie Perry, et al.
Kidney International|October 14, 2005
Regulation of collagen type IV genes is organ-specific: evidence from a canine model of Alport syndromeKeqin Zheng, Julie Perry, Scott J Harvey, et al.
Fertility and Sterility|June 21, 2024
Impact of relugolix combination therapy on functioning and quality of life in women with endometriosis-associated painSawsan As-Sanie, Mauricio S Abrao, Galyna Reznichenko, et al.
BMC Medical Education|June 3, 2014
Promoting medical students' reflection on competencies to advance a global health equities curriculumPatricia B Mullan, Joy Williams, Preeti N Malani, et al.
Microbiology (Reading, England)|May 29, 2007
The response regulator ComE in Streptococcus mutans functions both as a transcription activator of mutacin production and repressor of CSP biosynthesisJens Kreth, David C I Hung, Justin Merritt, et al.
The American Journal of Pathology|May 3, 2006
Sequential expression of type IV collagen networks: testis as a model and relevance to spermatogenesisScott J Harvey, Julie Perry, Keqin Zheng, et al.
Scientific Reports|February 29, 2024
End-to-end multimodal 3D imaging and machine learning workflow for non-destructive phenotyping of grapevine trunk internal structureRomain Fernandez, Loïc Le Cunff, Samuel Mérigeaud, et al.
Trials|July 24, 2025
RAPTOR: Randomised Controlled Trial of PENTOCLO (pentoxifylline-tocopherol-clodronate) in Mandibular Osteoradionecrosis-study protocol for an open-label phase II randomised controlled superiority trialRichard Shaw, Ruth Knight, Ayten Basoglu, et al.
Diabetes, Obesity & Metabolism|September 5, 2023
No evidence of compensatory changes in energy balance, despite reductions in body weight and liver fat, during dapagliflozin treatment in type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled, cross-over trial (ENERGIZE)Surya Panicker Rajeev, Carl Alexander Roberts, Emily Brown, et al.
Pageof 3